Aetna modified CPB 0580 for low vision programs, effective December 4, 2025. Here's what billing teams need to know.
Aetna, a CVS Health company, updated its low vision programs coverage policy under CPB 0580 in the Aetna CPB 0580 system. The revision clarifies medical necessity thresholds using best corrected visual acuity (BCVA) benchmarks and draws a hard line on device coverage — specifically excluding HCPCS codes V2600, V2610, and V2615. If your practice bills for optical or non-optical low vision aids for Aetna members, this change directly affects your reimbursement and your claim denial risk.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Low Vision Programs — CPB 0580 |
| Policy Code | CPB 0580 |
| Change Type | Modified |
| Effective Date | December 4, 2025 |
| Impact Level | Medium |
| Specialties Affected | Ophthalmology, Optometry, Low Vision Rehabilitation |
| Key Action | Remove V2600, V2610, and V2615 from Aetna charge capture and update ICD-10 documentation to confirm BCVA thresholds before billing low vision evaluations |
Aetna Low Vision Programs Coverage Criteria and Medical Necessity Requirements 2025
The coverage policy draws a clear line: Aetna covers the evaluation and training side of low vision programs. It does not cover the devices.
To meet medical necessity, a member must have a moderate or severe visual impairment that is not correctable by conventional refractive means. That phrase matters. If glasses or contacts can fix the problem, this policy does not apply.
Moderate visual impairment is defined as BCVA less than 20/60 in the better eye — specifically the range of 20/70 to 20/160. Severe visual impairment is BCVA less than 20/160 (covering 20/200 to 20/400), or a visual field diameter of 20° or less in the better eye. The visual field measure uses the largest field diameter for Goldman isopter III4e, 1/100 white test object, or equivalent.
These are not soft criteria. If the documentation doesn't include a BCVA reading in the medical record, you're exposed to a claim denial on medical necessity grounds. Train your ophthalmology and optometry teams to capture BCVA explicitly in the chart note — not just a general diagnosis of low vision.
Services Aetna considers medically necessary under this policy include ophthalmologic low vision evaluations and testing, instruction in the use of visual aids, interviews, and counseling. These are the billable services the policy supports. The low vision evaluation and the therapeutic instruction around it — not the devices themselves.
This policy does not mention prior authorization requirements, but that doesn't mean your specific plan is off the hook. Prior auth requirements live at the plan level, not just the CPB level. Check the member's benefit plan before scheduling services.
Aetna Low Vision Programs Exclusions and Non-Covered Indications
The exclusion here is broad and worth stating plainly: most Aetna plans do not cover low vision devices. Full stop.
This includes optical low vision devices — magnified visual aids of any kind — and non-optical devices like large-print books, enlarged telephone dials, and talking machines. These are contractually excluded. The mechanism isn't a medical necessity determination. The mechanism is a benefit exclusion. That distinction matters because no amount of documentation will fix a claim denial rooted in a benefit exclusion.
HCPCS codes V2600, V2610, and V2615 are explicitly listed as not covered under this CPB. If you're billing V2600 (hand held low vision aids and other nonspectacle mounted aids), V2610 (single lens spectacle mounted low vision aids), or V2615 (telescopic and other compound lens systems, including distance and near vision telescopic), expect denial on Aetna claims. This isn't ambiguous.
The policy does tell you to check benefit plan descriptions — and that's real advice, not boilerplate. Some Aetna plans may have different benefit structures, particularly employer-sponsored self-funded plans. If you're seeing mixed results on device claims across your Aetna book, that's likely plan variation. Pull the specific plan's benefit summary before appealing denials on V2600, V2610, or V2615.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Low vision evaluation and testing (BCVA < 20/60 in better eye, moderate impairment) | Covered | H54.2X11–H54.3, H54.50–H54.52A2 | Must document BCVA; not correctable by conventional refractive means |
| Low vision evaluation and testing (BCVA < 20/160 in better eye, severe impairment) | Covered | H54.0X33–H54.0X55, H54.10–H54.1225 | Includes blindness one or both eyes with documented BCVA |
| Low vision evaluation (visual field ≤ 20° in better eye) | Covered | H53.461–H53.469, H53.47 | Goldman isopter III4e or equivalent required in documentation |
| Instruction in use of visual aids; counseling | Covered | Diagnosis codes above | Therapeutic instruction — not device provision |
| Optical low vision devices (V2600, V2610, V2615) | Not Covered | V2600, V2610, V2615 | Contractually excluded from most Aetna plans; benefit exclusion, not medical necessity denial |
| Non-optical low vision aids (large-print books, enlarged dials, talking machines) | Not Covered | N/A — no specific HCPCS assigned | Benefit exclusion; check individual plan descriptions |
| Blindness, one eye (H54.40–H54.42A5) | Covered for evaluation component | H54.40–H54.42A5 | Must still meet BCVA or visual field thresholds in better eye |
Aetna Low Vision Programs Billing Guidelines and Action Items 2025
This is where the policy change translates into real work for your billing team. The effective date is December 4, 2025. If you haven't already made these updates, do it now.
| # | Action Item |
|---|---|
| 1 | Remove V2600, V2610, and V2615 from your Aetna charge capture. These codes are explicitly not covered under CPB 0580. Continuing to bill them generates denials and wastes staff time on appeals that won't succeed through the standard channel. If you believe a specific member's plan covers devices, verify the benefit description first — then bill. Don't bill first and ask questions later. |
| 2 | Update your low vision evaluation documentation templates to capture BCVA explicitly. The policy requires BCVA documentation to establish moderate or severe impairment. "Low vision" as a standalone diagnosis isn't enough. The chart note needs to show BCVA in the better eye — and confirm the impairment is not correctable by conventional refractive means. Build that into your intake or exam template. |
| 3 | Map your ICD-10-CM codes to the correct severity tier before billing. Moderate impairment maps to the H54.50–H54.52A2 and H54.2X11–H54.3 ranges. Severe impairment and blindness maps to H54.0X33–H54.0X55 and H54.10–H54.1225. Visual field defects map to H53.461–H53.469 and H53.47. Sloppy code selection is one of the fastest routes to a claim denial on this policy. |
| 4 | Verify prior authorization requirements at the plan level before scheduling. CPB 0580 doesn't specify prior auth requirements — but individual Aetna plans often do. Check the member's plan or call Aetna Provider Services before the service date, especially for high-cost evaluations or multi-visit programs. |
| 5 | Audit any open or pending Aetna low vision claims for device codes. If you have claims in process that include V2600, V2610, or V2615, pull them now. Resubmit without the device codes if the evaluation services are separately billable and supported by documentation. Don't leave those claims to time out and count as denials. |
| 6 | Review the benefit plan description for self-funded Aetna accounts in your payer mix. The policy notes that most — not all — Aetna plans exclude device coverage. Self-funded employers have more flexibility. If you serve a mix of Aetna plan types, the device exclusion may not apply universally. Your billing team needs to know which accounts are exceptions before writing off device reimbursement across the board. |
If you're uncertain how this policy interacts with your specific Aetna contracts or your practice's mix of plan types, loop in your compliance officer or a billing consultant before the December 4, 2025 effective date passes without action.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Low Vision Programs Under CPB 0580
Not Covered HCPCS Codes
These three codes are explicitly excluded from coverage under CPB 0580. Do not bill these on Aetna claims unless you've confirmed the specific plan's benefit structure covers low vision devices.
| Code | Type | Description | Reason |
|---|---|---|---|
| V2600 | HCPCS | Hand held low vision aids and other nonspectacle mounted aids | Not covered for indications listed in CPB 0580 |
| V2610 | HCPCS | Single lens spectacle mounted low vision aids | Not covered for indications listed in CPB 0580 |
| V2615 | HCPCS | Telescopic and other compound lens system, including distance vision telescopic, near vision telescopic | Not covered for indications listed in CPB 0580 |
Key ICD-10-CM Diagnosis Codes
These are the diagnosis codes the policy references for low vision programs billing. Pair these with your evaluation and counseling services when billing medically necessary low vision programs.
| Code | Description |
|---|---|
| H53.461 | Homonymous bilateral field defects |
| H53.462 | Homonymous bilateral field defects |
| H53.463 | Homonymous bilateral field defects |
| H53.464 | Homonymous bilateral field defects |
| H53.465 | Homonymous bilateral field defects |
| H53.466 | Homonymous bilateral field defects |
| H53.467 | Homonymous bilateral field defects |
| H53.468 | Homonymous bilateral field defects |
| H53.469 | Homonymous bilateral field defects |
| H53.47 | Heteronymous bilateral field defects |
| H54.0X33–H54.0X55 | Blindness, both eyes |
| H54.10–H54.1225 | Blindness, one eye, low vision other eye |
| H54.2X11–H54.3 | Low vision, both eyes |
| H54.40–H54.42A5 | Blindness, one eye |
| H54.50–H54.52A2 | Low vision, one eye |
A note on the H53.46x codes: the policy lists nine separate laterality sub-codes under homonymous bilateral field defects. Select the correct sub-code based on the documented laterality in the medical record. Billing the wrong sub-code generates a claim denial on specificity grounds. It's a small error with a real cost.
The H54 range covers the spectrum from low vision in one eye to blindness in both eyes. Your documentation needs to support the specific code you choose — which means the BCVA reading in the chart note has to match the severity tier the code represents.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.